MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAllister, G.
Right arrow Articles by Beer, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAllister, G.
Right arrow Articles by Beer, M. S.

Vol. 58, Issue 2, 407-412, August 2000

Edg2 Receptor Functionality: Gialpha 1 Coexpression and Fusion Protein Studies

George McAllister, Josephine A. Stanton, Kamran Salim, Emma J. Handford, and Margaret S. Beer

Department of Biochemistry, Merck, Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Harlow, Essex, United Kingdom

Recombinant receptor cell lines are widely used in G-protein-coupled receptor selectivity studies. To unequivocally interpret the results of such studies, it is essential that the host cell line does not endogenously express the receptor of interest and in addition is unresponsive to the receptor's natural ligand. Here we describe an approach to overcome such difficulties associated with orphan receptors or, as in the present case, receptors whose endogenous ligand ubiquitously affects mammalian cells. The functional heterologous assay system described is for the hEdg2 receptor, which uses lysophosphatidic acid as its endogenous ligand. Once activated, this receptor mediates its effects via multiple secondary messenger pathways, including a Gi-coupled pathway. We have transiently expressed a pertussis toxin-insensitive hEdg2 receptor-ratGialpha 1 fusion protein into human embryonic kidney cells and have monitored the ability of compounds to stimulate [35S]GTPgamma S binding in membranes prepared from these cells after pretreatment with toxin. Because the assay conditions used favor Gi-mediated responses and because endogenous Gialpha subunits are rendered inactive, the response measured is, by definition, fusion protein-mediated. Consequently, we have developed an assay that monitors definitively Edg2 receptor-mediated responses in a mammalian cell line. A limited structure activity relationship study suggests that the lysophospholipid carbon chain has a role in receptor activation and in addition indicates that certain modifications to the phosphate group are tolerated.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J BiochemHome page
S. Takeda, T. Okada, M. Okamura, T. Haga, J. Isoyama-Tanaka, H. Kuwahara, and N. Minamino
The Receptor-G{alpha} Fusion Protein as a Tool for Ligand Screening: a Model Study Using a Nociceptin Receptor-G{alpha}i2 Fusion Protein
J. Biochem., May 1, 2004; 135(5): 597 - 604.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
H. Suga, S. Takeda, T. Haga, M. Okamura, K. Takao, and K. Tatemoto
Stimulation of Increases in Intracellular Calcium and Prostaglandin E2 Generation in Chinese Hamster Ovary Cells Expressing Receptor-G{alpha}16 Fusion Proteins
J. Biochem., May 1, 2004; 135(5): 605 - 613.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Molinari, C. Ambrosio, D. Riitano, M. Sbraccia, M. C. Gro, and T. Costa
Promiscuous Coupling at Receptor-Galpha Fusion Proteins. THE RECEPTOR OF ONE COVALENT COMPLEX INTERACTS WITH THE alpha -SUBUNIT OF ANOTHER
J. Biol. Chem., April 25, 2003; 278(18): 15778 - 15788.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Hasegawa, J. R. Erickson, G. J. Goddard, S. Yu, S. Liu, K. W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, et al.
Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 Receptor
J. Biol. Chem., March 28, 2003; 278(14): 11962 - 11969.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. E. Heise, W. L. Santos, A. M. Schreihofer, B. H. Heasley, Y. V. Mukhin, T. L. Macdonald, and K. R. Lynch
Activity of 2-Substituted Lysophosphatidic Acid (LPA) Analogs at LPA Receptors: Discovery of a LPA1/LPA3 Receptor Antagonist
Mol. Pharmacol., December 1, 2001; 60(6): 1173 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D.-a. Wang, Z. Lorincz, D. L. Bautista, K. Liliom, G. Tigyi, and A. L. Parrill
A Single Amino Acid Determines Lysophospholipid Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors
J. Biol. Chem., December 21, 2001; 276(52): 49213 - 49220.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics